Showing results (41-50 of 114) with videos related to
Sort By:
Pageof 12
HIV Clinical Trials|October 23, 2013
Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384Gregory K Robbins, Marcia A Testa, Max Su, et al.AIDS (London, England)|June 24, 2003
Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunizationGregory K Robbins, Marylyn M Addo, Hien Troung, et al.The Journal of Infectious Diseases|April 19, 2008
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapyTodd Hulgan, Pablo Tebas, Jeffrey A Canter, et al.The Journal of Infectious Diseases|July 14, 2009
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjectsSamir K Gupta, Lauren Komarow, Roy M Gulick, et al.The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.Sexually Transmitted Infections|August 28, 2010
Ocular syphilis among HIV-infected patients: a systematic analysis of the literatureJoseph D Tucker, Jonathan Z Li, Gregory K Robbins, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based SeriesEric A Meyerowitz, Shibani S Mukerji, G Kyle Harrold, et al.Plos One|September 13, 2012
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384Todd Hulgan, Gregory K Robbins, Spyros A Kalams, et al.The Journal of Infectious Diseases|July 18, 2006
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotypeCarolynne Schwarze-Zander, Jason T Blackard, Hui Zheng, et al.AIDS (London, England)|July 19, 2006
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapyAsha R Kallianpur, Todd Hulgan, Jeffrey A Canter, et al.Pageof 12